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ydro-1H-Abstract In this study, seven new 3-alkyl(aryl)-4-[3,4-di-(4-nitrobenzoxy)-benzylidenamino]-4,5-
dihydro-1H-1,2,4-triazol-5-ones (4) were synthesized by the reactions of 3-alkyl(aryl)-4-amino-
4,5-dihydro-1H-1,2,4-triazol-5-ones (2) with 3,4-di-(4-nitrobenzoxy)-benzaldehyde (3) which had
also been synthesized by the reactions of 3,4-dihydroxybenzaldehyde with 4-nitrobenzoyl chloride
by using triethylamine. The acetylation reactions of compounds 4 were investigated and six new 5
type compounds were obtained. The new thirteen compounds were characterized by elemental anal-
yses and IR, 1H NMR, 13C NMR, UV and mass spectral data. In addition, the synthesized com-
pounds were analysed for their in vitro potential antioxidant activities in three different methods.
Compound 4g showed the best activity for antioxidant results. Moreover, the compounds 4 were
titrated potentiometrically with tetrabutylammonium hydroxide (TBAH) in four non-aqueous sol-
vents. Thus, the half-neutralization potential values and the corresponding pKa values were deter-
mined in all cases.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
In the last two decades there has been an increasing interest in
the role of reactive oxygen species (ROS) and of reactiveDepartment of Chemistry,
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1,2,4-triazol-5-one derivatives. Anitrogen species (RNS) in food, drugs, and even living system.
Therefore, scientists in various disciplines have become more
interested in naturally-occurring antioxidants as well as in re-
lated synthetic derivatives that could provide active compo-
nents which prevent or reduce the impact of oxidative stress
(Hussain et al., 2003).
Exogenous chemicals and endogenous metabolic processes
in the human body or in the food system might produce highly
reactive free radicals, especially oxygen-derived radicals. At
high concentrations, they can be important mediators of dam-
age among cell structures, including lipids and membranes,
proteins, and nucleic acids (McClements and Decker, 2000).
In this regard, it is important to search for and synthesize
new classes of compounds that have antioxidant properties.ier B.V. All rights reserved.
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2 O¨. Gu¨rsoy-Kol, E. Ayazog˘lu1,2,4-Triazole and 4,5-dihydro-1H-1,2,4-triazol-5-one
derivatives are reported to possess a broad spectrum of biolog-
ical activities such as antibacterial (Yuksek et al., 1997; Pitucha
et al., 2010), antifungal (Kahveci et al., 2008), antioxidant
(Arslantas et al., 2012; Gursoy-Kol et al., 2012), anti-inﬂam-
matory (Uzgoren-Baran et al., 2012), anticonvulsant (Zhang
et al., 2012), antiparasitic (Saadeh et al., 2010), analgesic
(Chidananda et al., 2012), antiviral (Henen et al., 2012), anti-
tumor (Demirbas et al., 2002), anti-HIV (Li et al., 2013), anti-
hypertensive and diuretic (Ali et al., 2011) properties. In
addition, several articles reporting the synthesis of some N-
arylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives
have been published so far (Yuksek et al., 1997; Arslantas
et al., 2012; Gursoy-Kol et al., 2012).
On the other hand, it is known that 1,2,4-triazole and 4,5-
dihydro-1H-1,2,4-triazol-5-one rings have weak acidic proper-
ties, so that some 1,2,4-triazole and 4,5-dihydro-1H-1,2,4-tria-
zol-5-one derivatives were titrated potentiometrically with
TBAH in non-aqueous solvents, and the pKa values of the
compounds were determined (Arslantas et al., 2012; Gursoy-
Kol et al., 2012).
In the present study, due to a wide range of applications to
ﬁnd their possible antioxidant activity, the newly synthesized
4,5-dihydro-1H-1,2,4-triazol-5-one derivatives were investi-
gated by using different antioxidant methodologies such as:
reducing power, 1,1-diphenyl-2-picryl-hydrazyl (DPPH) free
radical scavenging and metal chelating activities. Besides, in
order to determine the pKa values of the compounds, they were
titrated potentiometrically with TBAH in four non-aqueous
solvents, including isopropyl alcohol, tert-butyl alcohol, ace-
tone and N,N-dimethylformamide (DMF).
2. Materials and methods
2.1. Chemical reagents and apparatus
Chemical reagents used in this study were purchased from
Merck AG, Aldrich and Fluka. Melting points were deter-
mined in open glass capillaries using a WRS-2A Microproces-
sor melting point apparatus and are uncorrected. The IR
spectra were recorded on an Alpha-P Bruker FT-IR spectrom-
eter. 1H and 13C NMR spectra were recorded in deuterated di-
methyl sulfoxide with TMS as internal standard using a Bruker
spectrometer at 200 and 50 MHz, respectively. UV absorption
spectra were measured in 10 mm quartz cells between 200 and
400 nm using a PG Instruments Ltd T80 UV/vis spectrometer.
Extinction coefﬁcients (e) are expressed in L mol1 cm1. Ele-
mental analyses were carried out on a LECO, CHNS-932 for
C, H, and N. Mass spectra were recorded on a Thermo Scien-
tiﬁc DSQ II Single Quadrupole GC/MS in the electron impact
(EI) ionization mode (70 eV).
2.2. General procedure for the synthesis of compounds 4
3,4-Dihydroxybenzaldehyde (0.01 mol) dissolved in ethyl ace-
tate (100 mL) was treated with 4-nitrobenzoyl chloride
(0.02 mol), and to this solution was slowly added triethylamine
(0.02 mol) with stirring at 0–5 C. Stirring was continued for
2 h, and then the mixture was reﬂuxed for 3 h and ﬁltered.
The ﬁltrate was evaporated in vacuo, and the crude product
was washed with water and recrystallized from DMSO-H2OPlease cite this article in press as: Gu¨rsoy-Kol, O¨., Ayazog˘lu, E. Antioxida
oxy)-benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives. A
j.arabjc.2013.11.015(1:3) to afford compound 3, yield 5.82 g (98%). mp 164 C;
IR (KBr) (m, cm1): 2842 and 2739 (CHO); 1739, 1670
(C‚O); 1516 and 1347 (NO2); 1239 (COO); 828 (1,4-disubsti-
tuted benzenoid ring). 1H NMR (DMSO-d6): d 7.20 (d, 1H,
ArH), 7.77–7.81 (m, 1H, Ar-H), 8.16–8.19 (m, 2H, Ar-H),
8.21–8.26 (m, 1H, Ar-H), 8.32–8.64 (m, 6H, Ar-H), 9.79 (s,
1H, CHO). 13C NMR (DMSO-d6): d 117.77, 124.13 (2C),
124.53 (2C), 124.72, 129.11, 130.42, 131.12 (2C), 131.81 (2C),
134.59, 136.94, 139.03, 150.42, 151.04, 155.52 (Ar-C), 163.10,
166.28 (COO), 190.99 (CHO). UV kmax (e): 256 (16,437), 240
(16,523), 218 (16,145) nm. The corresponding compound 2
(0.01 mol) was dissolved in acetic acid (15 mL) and treated
with 3,4-di-(4-nitrobenzoxy)-benzaldehyde 3 (0.01 mol). The
mixture was reﬂuxed for 1.5 h and then evaporated at 50–
55 C in vacuo. Several recrystallizations of the residue from
appropriate solvent gave pure compounds 4a–g as colourless
crystals.
2.2.1. 3-Methyl-4-[3,4-di-(4-nitrobenzoxy)-benzylidenamino]-
4,5-dihydro-1H-1,2,4-triazol-5-one (4a)
Yield 5.09 g (95%). Mp 303 C. IR (KBr): 3171 (NH); 1743,
1712 (C‚O); 1604 (C‚N); 1518 and 1355 (NO2); 1250
(COO); 851 (1,4-disubstituted benzenoid ring) cm1. 1H
NMR (DMSO-d6): d 2.31 (s, 3H, CH3), 7.77 (d, 1H, Ar-H),
7.96 (d, 1H, Ar-H), 8.14 (m, 1H, Ar-H), 8.22–8.26 (m, 4H,
Ar-H), 8.32–8.34 (m, 4H, Ar-H), 9.84 (s, 1H, N‚CH), 11.89
(s, 1H, NH). 13C NMR (DMSO-d6): d 11.58 (CH3), 122.64,
124.60, 124.62 (2C), 125.31, 127.79, 129.62, 131.70 (2C),
131.76, 133.65, 135.70, 142.63, 142.77, 144.24, 144.82, 151.30,
151.64 (arom-C), 146.72 (triazole C3), 151.25 (N‚CH),
151.96 (triazole C5), 162.29, 162.64 (COO). UV kmax (e): 262
(18,858), 212 (30,476) nm. Anal. Calcd for C24H16N6O9
(532.43): C 54.14, H 3.03, N 15.78. Found: C 53.71, H 3.09,
N 14.58. MS (GC) m/z= 555 [M+23].
2.2.2. 3-Ethyl-4-[3,4-di-(4-nitrobenzoxy)-benzylidenamino]-
4,5-dihydro-1H-1,2,4-triazol-5-one (4b)
Yield 5.16 g (95%). Mp 265 C. IR (KBr): 3176 (NH); 1744,
1710 (C‚O); 1602 (C‚N); 1520 and 1355 (NO2); 1253
(COO); 851 (1,4-disubstituted benzenoid ring) cm1. 1H
NMR (DMSO-d6): d 1.22 (t, 3H, CH2CH3), 2.72 (q, 2H, CH2-
CH3), 7.77 (d, 1H, Ar-H), 7.95 (d, 1H, Ar-H), 8.12 (m, 1H, Ar-
H), 8.22–8.26 (m, 4H, Ar-H), 8.31–8.34 (m, 4H, Ar-H), 9.83 (s,
1H, N‚CH), 11.92 (s, 1H, NH). 13C NMR (DMSO-d6): d
10.48 (CH2CH3), 18.91 (CH2CH3), 122.66, 124.23 (3C),
124.60 (2C), 125.00, 127.71, 131.18, 131.70 (2C), 131.86 (2C),
133.63, 142.64, 144.23, 151.23, 151.79 (arom-C), 148.56 (tria-
zole C3), 151.23 (N‚CH), 152.01 (triazole C5), 162.48,
162.63 (COO). UV kmax (e): 260 (21,800), 214 (27,200) nm.
MS (GC) m/z= 546 [M]; C25H18N6O9.
2.2.3. 3-Benzyl-4-[3,4-di-(4-nitrobenzoxy)-benzylidenamino]-
4,5-dihydro-1H-1,2,4-triazol-5-one (4c)
Yield 5.87 g (97%). Mp 240 C. IR (KBr): 3165 (NH); 1749,
1715 (C‚O); 1586 (C‚N); 1522 and 1348 (NO2); 1246
(COO); 825 (1,4-disubstituted benzenoid ring); 777 and 709
(monosubstituted benzenoid ring) cm1. 1H NMR (DMSO-
d6): d 4.09 (s, 2H, CH2Ph), 7.18–7.36 (m, 5H, Ar-H), 7.75 (d,
1H, Ar-H), 7.91 (d, 1H, Ar-H), 8.05 (m, 1H, Ar-H), 8.18–8.27
(m, 3H, Ar-H), 8.31–8.34 (m, 3H, Ar-H), 8.36–8.44 (m, 2H,
Ar-H), 9.80 (s, 1H, N‚CH), 12.07 (s, 1H, NH). 13C NMRnt activities and acidic properties of some novel 4-[3,4-di-(4-nitrobenz-
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Some properties of 4,5-dihydro-1H-1,2,4-triazol-5-one Derivatives 3(DMSO-d6): d 31.53 (CH2Ph), 117.80, 122.69, 124.51, 124.59,
124.94, 125.58, 127.19, 127.65, 128.84, 128.90 (2C), 129.31,
129.35 (2C), 131.41 (2C), 131.83, 133.54, 133.67, 136.23, 142.56,
144.18, 151.56, 152.56 (arom-C), 146.76 (triazole C3), 151.23
(N‚CH), 153.34 (triazole C5), 162.48, 163.15 (COO). UV kmax
(e): 262 (18,842), 214 (32,713) nm. Anal. Calcd for C30H20N6O9
(608.52): C 59.21, H 3.31, N 13.81. Found: C 57.73, H 3.46, N
13.61. MS (GC) m/z= 608 [M].2.2.4. 3-p-Methylbenzyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (4d)
Yield 6.06 g (98%). Mp 230 C. IR (KBr): 3167 (NH); 1747,
1698 (C‚O); 1595 (C‚N); 1527 and 1348 (NO2); 1244
(COO); 841, 805 (1,4-disubstituted benzenoid ring) cm1. 1H
NMR (DMSO-d6): d 2.22 (s, 3H, PhCH3), 4.03 (s, 2H, CH2-
Ph), 7.05–7.23 (m, 4H, Ar-H), 7.75 (d, 1H, Ar-H), 7.91 (d,
1H, Ar-H), 8.05 (m, 1H, Ar-H), 8.23–8.27 (m, 3H, Ar-H),
8.31–8.35 (m, 3H, Ar-H), 8.37–8.46 (m, 2H, Ar-H), 9.78 (s,
1H, N = CH), 12.03 (s, 1H, NH). 13C NMR (DMSO-d6): d
21.05 (PhCH3), 31.15 (CH2Ph), 117.78, 122.65, 124.49,
124.57, 124.92 (2C), 127.64, 129.17, 129.91 (2C), 129.45 (2C),
129.53, 131.67 (2C), 131.82, 133.09, 133.56, 133.66, 136.30,
142.55, 144.16, 151.20, 151.61 (arom-C), 146.89 (triazole C3),
151.04 (N‚CH), 152.54 (triazole C5), 162.47, 163.15 (COO).
UV kmax (e): 262 (24,184), 218 (27,883) nm. Anal. Calcd for
C31H22N6O9 (622.55): C 59.81, H 3.56, N 13.50. Found: C
58.98, H 3.69, N 13.65. MS (GC) m/z= 622 [M].2.2.5. 3-p-Chlorobenzyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (4e)
Yield 5.94 g (92%). Mp 241 C. IR (KBr): 3198 (NH); 1744,
1705 (C‚O); 1604 (C‚N); 1522 and 1351 (NO2); 1253
(COO); 850, 802 (1,4-disubstituted benzenoid ring) cm1. 1H
NMR (DMSO-d6): d 4.07 (s, 2H, CH2Ph), 7.31–7.39 (m, 4H,
Ar-H), 7.74 (d, 1H, Ar-H), 7.90 (d, 1H, Ar-H), 8.05 (m, 1H,
Ar-H), 8.20–8.27 (m, 4H, Ar-H), 8.31–8.34 (m, 4H, Ar-H),
9.80 (s, 1H, N‚CH), 12.08 (s, 1H, NH). 13C NMR (DMSO-
d6): d 30.85 (CH2Ph), 122.64, 124.61 (3C), 124.96, 127.78,
128.83 (3C), 131.31 (3C), 131.70 (3C), 131.89, 133.50, 133.62,
133.68, 135.20, 142.57, 144.21, 151.23, 151.60 (arom-C),
146.44 (triazole C3), 151.23 (N‚CH), 151.60 (triazole C5),
162.49, 162.59 (COO). UV kmax (e): 262 (27,700), 216
(34,857) nm. Anal. Calcd for C30H19ClN6O9 (642.97): C
56.04, H 2.98, N 13.07. Found: C 54.69, H 3.12, N 12.48.
MS (GC) m/z= 642 [M].2.2.6. 3-m-Chlorobenzyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (4f)
Yield 6.03 g (94%). Mp 242 C. IR (KBr): 3197 (NH); 1745,
1715 (C‚O); 1601 (C‚N); 1521 and 1353 (NO2); 1254
(COO); 849 (1,4-disubstituted benzenoid ring); 790 and 711
(1,3-disubstituted benzenoid ring) cm1. 1H NMR (DMSO-
d6): d 4.12 (s, 2H, CH2Ph), 7.25–7.45 (m, 4H, Ar-H), 7.76 (d,
1H, Ar-H), 7.91 (d, 1H, Ar-H), 8.05 (m, 1H, Ar-H), 8.31–
8.41 (m, 8H, Ar-H), 9.80 (s, 1H, N‚CH), 12.08 (s, 1H,
NH). 13C NMR (DMSO-d6): d 31.15 (CH2Ph), 122.44,
124.53, 124.61 (2C), 124.64, 124.99, 127.15, 127.22, 127.96,
128.02, 129.54, 130.70, 130.76, 131.70, 131.84 (2C), 133.37,
133.52, 133.63, 138.64, 142.60, 144.26, 151.26, 151.63 (arom-Please cite this article in press as: Gu¨rsoy-Kol, O¨., Ayazog˘lu, E. Antioxida
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j.arabjc.2013.11.015C), 146.26 (triazole C3), 151.08 (N‚CH), 152.62 (triazole
C5), 162.47, 162.61 (COO). UV kmax (e): 262 (20,197), 214
(34,239) nm. Anal. Calcd for C30H19ClN6O9 (642.97): C
56.04, H 2.98, N 13.07. Found: C 55.02, H 3.07, N 12.88.
MS (GC) m/z= 642 [M].
2.2.7. 3-Phenyl-4-[3,4-di-(4-nitrobenzoxy)-benzylidenamino]-
4,5-dihydro-1H-1,2,4-triazol-5-one (4g)
Yield 5.82 g (98%). Mp 261 C. IR (KBr): 3172 (NH); 1734,
1716 (C‚O); 1606 (C‚N); 1520 and 1350 (NO2); 1255
(COO); 849 (1,4-disubstituted benzenoid ring); 762 and 709
(monosubstituted benzenoid ring) cm1. 1H NMR (DMSO-
d6): d 7.50–7.57 (m, 4H, Ar-H), 7.78 (d, 1H, Ar-H), 7.88–
7.96 (m, 2H, Ar-H), 8.08 (m, 1H, Ar-H), 8.30–8.33 (m, 4H,
Ar-H), 8.36–8.39 (m, 4H, Ar-H), 9.76 (s, 1H, N‚CH), 12.45
(s, 1H, NH). 13C NMR (DMSO-d6): d 123.28, 124.14,
124.46, 124.55, 124.58, 125.11, 126.99, 127.48, 128.28, 128.45,
129.00 (2C), 129.05, 130.64, 131.67, 131.69, 131.84, 133.27,
133.60, 133.69, 142.61, 144.40, 151.20, 151.88 (arom-C),
145.47 (triazole C3), 151.03 (N‚CH), 155.13 (triazole C5),
162.46, 162.57 (COO). UV kmax (e): 262 (13,588), 212
(25,280) nm. Anal. Calcd for C29H18N6O9 (594.50): C 58.59,
H 3.05, N 14.14. Found: C 57.44, H 3.13, N 13.84. MS (GC)
m/z= 594 [M].2.3. General procedure for the synthesis of compounds 5
The corresponding compound 4 (0.01 mol) was reﬂuxed with
acetic anhydride (20 mL) for 0.5 h. After the addition of abso-
lute ethanol (100 mL), the mixture was reﬂuxed for 1 h. Evap-
oration of the resulting solution at 40–45 C in vacuo and
several recrystallizations of the residue from EtOH gave pure
compounds 5 as colourless needles.
2.3.1. 1-Acetyl-3-methyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (5a)
Yield 5.32 g (93%). Mp 206 C. IR (KBr): 1766, 1740, 1720
(C‚O); 1605 (C‚N); 1523 and 1349 (NO2); 1240 (COO);
817 (1,4-disubstituted benzenoid ring) cm1. 1H NMR
(DMSO-d6): d 2.34 (s, 3H, CH3), 2.51 (s, 3H, COCH3), 7.79–
8.34 (m, 11H, Ar-H), 9.73 (s, 1H, N‚CH). UV kmax (e): 258
(10,862), 210 (37,270) nm. Anal. Calcd for C26H18N6O10
(574.46): C 54.36, H 3.16, N 14.63. Found: C 53.76, H 3.23,
N 14.27. MS (GC) m/z= 597 [M+23].2.3.2. 1-Acetyl-3-ethyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (5b)
Yield 5.32 g (91%). Mp 158 C. IR (KBr): 1770, 1743, 1722
(C‚O); 1607 (C‚N); 1525 and 1352 (NO2); 1256 (COO);
847 (1,4-disubstituted benzenoid ring) cm1. 1H NMR
(DMSO-d6): d 1.21–1.28 (m, 3H, CH2CH3), 2.21 (s, 3H,
COCH3), 2.75–2.82 (m, 2H, CH2CH3), 7.55 (d, 1H, Ar-H),
7.90–7.93 (m, 1H, Ar-H), 8.08 (m, 1H, Ar-H), 8.23–8.26 (m,
2H, Ar-H), 8.31–8.37 (m, 4H, Ar-H), 8.45–8.47 (m, 2H, Ar-
H), 9.67 (s, 1H, N‚CH). 13C NMR (DMSO-d6): d 9.91
(CH2CH3), 19.00 (CH2CH3), 23.95 (COCH3), 122.92, 124.59,
124.72 (2C), 125.06, 127.89, 131.70, 131.82 (2C), 132.48,
133.06, 133.67, 133.91, 142.79, 144.62, 144.89, 151.24, 151.30
(arom-C), 148.53 (triazole C3), 150.66 (N‚CH), 154.13 (tria-
zole C5), 162.59, 166.46 (COO), 168.43 (COCH3). UV kmaxnt activities and acidic properties of some novel 4-[3,4-di-(4-nitrobenz-
rabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/
4 O¨. Gu¨rsoy-Kol, E. Ayazog˘lu(e): 254 (33,688), 216 (34,975) nm. Anal. Calcd for
C27H20N6O10 (588.49): C 55.11, H 3.43, N 14.28. Found: C
54.41, H 3.68, N 13.54. MS (GC) m/z= 588 [M].2.3.3. 1-Acetyl-3-benzyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (5c)
Yield 5.95 g (92%). Mp 123 C. IR (KBr): 1767, 1743 (C‚O);
1606 (C‚N); 1524 and 1351 (NO2); 1256 (COO); 850 (1,4-
disubstituted benzenoid ring); 765 and 709 (monosubstituted
benzenoid ring) cm1. 1H NMR (DMSO-d6): d 2.25 (s, 3H,
COCH3), 4.16 (s, 2H, CH2Ph), 7.20–7.42 (m, 7H, Ar-H),
7.53 (d, 1H, Ar-H), 7.81–7.85 (m, 1H, Ar-H), 8.05 (m, 1H,
Ar-H), 8.23–8.27 (m, 1H, Ar-H), 8.32–8.38 (m, 3H, Ar-H),
8.44–8.48 (m, 2H, Ar-H), 9.63 (s, 1H, N‚CH). 13C NMR
(DMSO-d6): d 24.00 (COCH3), 31.47 (CH2Ph), 122.92,
124.59, 124.76 (2C), 124.90, 125.00, 127.43, 127.90, 128.96
(2C), 129.54 (2C), 131.69, 131.80 (2C), 132.46, 133.88,
135.13, 142.76, 142.77, 144.88, 148.44, 151.24, 151.31 (arom-
C), 148.78 (triazole C3), 151.31 (N‚CH), 153.61 (triazole
C5), 162.56, 166.43 (COO), 168.45 (COCH3). UV kmax (e):
250 (32,259), 226 (32,159) nm. Anal. Calcd for C32H22N6O10
(650.56): C 59.08, H 3.41, N 12.92. Found: C 59.24, H 4.13,
N 12.37. MS (GC) m/z= 650 [M].2.3.4. 1-Acetyl-3-p-methylbenzyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (5d)
Yield 6.54 g (99%). Mp 247 C. IR (KBr): 1767, 1743, 1723
(C‚O); 1605 (C‚N); 1524 and 1349 (NO2); 1254 (COO);
848 (1,4-disubstituted benzenoid ring) cm1. 1H NMR
(DMSO-d6): d 2.21 (s, 3H, CH3), 2.26 (s, 3H, COCH3), 4.10
(s, 2H, CH2Ph), 7.07–7.28 (m, 5H, Ar-H), 7.52 (d, 1H, Ar-
H), 7.76–7.78 (m, 1H, Ar-H), 8.00 (m, 1H, Ar-H), 8.23–8.27
(m, 2H, Ar-H), 8.31–8.38 (m, 3H, Ar-H), 8.44–8.48 (m, 2H,
Ar-H), 9.62 (s, 1H, N‚CH). 13C NMR (DMSO-d6): d 21.06
(PhCH3), 23.98 (COCH3), 31.11 (CH2Ph), 122.95, 124.58,
124.61, 124.75, 124.99, 129.19, 129.40, 129.43, 129.44, 129.51,
131.69, 131.80, 131.96, 132.47, 133.03, 133.87, 133.91, 136.22,
136.53, 142.68, 144.83, 146.87, 151.22, 151.61 (arom-C),
148.42 (triazole C3), 148.91 (N‚CH), 153.56 (triazole C5),
162.55, 166.42 (COO), 168.44 (COCH3). UV kmax (e): 258
(47,996), 222 (49,726) nm. Anal. Calcd for C33H24N6O10
(664.59): C 59.64, H 3.64, N 12.65. Found: C 58.79, H 4.13,
N 12.54. MS (GC) m/z= 687 [M+23].
2.3.5. 1-Acetyl-3-p-chlorobenzyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (5e)
Yield 6.26 g (92%). Mp 168 C. IR (KBr): 1768, 1740 (C‚O);
1606 (C‚N); 1519 and 1351 (NO2); 1259 (COO); 847, 801
(1,4-disubstituted benzenoid ring) cm1. 1H NMR (DMSO-
d6): d 2.23 (s, 3H, COCH3), 4.10 (s, 2H, CH2), 7.34–7.44 (m,
6H, Ar-H), 7.53 (d, 1H, Ar-H), 7.87–7.89 (m, 1H, Ar-H),
8.09 (m, 1H, Ar-H), 8.23–8.27 (m, 1H, Ar-H), 8.31–8.40 (m,
3H, Ar-H), 8.45–8.48 (m, 2H, Ar-H), 9.64 (s, 1H, N‚CH).
13C NMR (DMSO-d6): d 23.99 (COCH3), 30.82 (CH2Ph),
122.64, 124.60, 124.75 (2C), 124.91, 125.01, 127.55, 128.00,
128.88 (2C), 131.28 (2C), 131.48, 131.70 (2C), 131.81, 132.17,
132.44, 132.78, 133.88, 142.73, 144.86, 151.31, 151.60 (arom-
C), 146.43 (triazole C3), 148.48 (N‚CH), 153.52 (triazole
C5), 162.57, 166.41 (COO), 168.44 (COCH3). UV kmax (e):
302 (26,771), 286 (29,447), 242 (32,881) nm. Anal. Calcd forPlease cite this article in press as: Gu¨rsoy-Kol, O¨., Ayazog˘lu, E. Antioxida
oxy)-benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives. A
j.arabjc.2013.11.015C32H21ClN6O10 (685.01): C 56.11, H 3.09, N 12.27. Found:
C 54.75, H 3.48, N 11.89. MS (GC) m/z= 708 [M+23].
2.3.6. 1-Acetyl-3-phenyl-4-[3,4-di-(4-nitrobenzoxy)-
benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one (5g)
Yield 6.26 g (99%). Mp 279 C. IR (KBr): 1772, 1733, 1707
(C‚O); 1607 (C‚N); 1523 and 1346 (NO2); 1245 (COO);
851 (1,4-disubstituted benzenoid ring); 771 and 691 (monosub-
stituted benzenoid ring) cm1. 1H NMR (DMSO-d6): d 2.28 (s,
3H, COCH3), 7.58–7.68 (m, 5H, Ar-H), 7.85–8.00 (m, 5H, Ar-
H), 8.22–8.25 (m, 1H, Ar-H), 8.31–8.46 (m, 5H, Ar-H), 9.71 (s,
1H, N‚CH). 13C NMR (DMSO-d6): d 24.07 (COCH3),
123.20, 124.36, 124.49 (2C), 124.72, 125.22, 127.07, 127.33,
128.28 (2C), 128.42, 129.06 (2C), 129.15, 129.21, 130.87,
131.80 (2C), 132.71, 133.84, 142.73, 144.67, 151.28, 151.73
(arom-C), 146.49 (triazole C3), 148.60 (N‚CH), 155.38 (tria-
zole C5), 162.56, 166.75 (COO), 168.46 (COCH3). UV kmax
(e): 262 (26,431), 214 (32,125) nm. MS (GC) m/z= 675
[M+39]; C31H20N6O10.
2.4. Antioxidant activity: chemicals
Butylated hydroxytoluene (BHT) was obtained from E. Merck.
Ferrous chloride, a-tocopherol, DPPH, 3-(2-pyridyl)-5,6-
bis(phenylsulfonic acid)-1,2,4-triazine (ferrozine), butylated
hydroxyanisole (BHA), ethylenediaminetetraacetic acid (EDTA)
and trichloroacetic acid (TCA) were obtained from Sigma.
2.4.1. Reducing power
The reducing power of the synthesized compounds was deter-
mined according to the method of Oyaizu (1986) as explained
in Arslantas et al., 2012; Gursoy-Kol et al., 2012.
2.4.2. Free radical scavenging activity
Free radical scavenging activity of compounds was measured
by DPPH, using the method of Blois (1958) as explained in
Arslantas et al., 2012; Gursoy-Kol et al., 2012.
2.4.3. Metal chelating activity
The chelation of ferrous ions by the synthesized compounds
and standards was estimated by the method of Dinis et al.
(1994) as explained in Arslantas et al., 2012; Gursoy-Kol
et al., 2012.
2.5. Potentiometric titrations
A Jenco model ion analyser and an Ingold pH electrode were
used for potentiometric titrations. For each compound that
was titrated, the 0.001 M solution was separately prepared in
each non-aqueous solvent. The 0.05 M solution of TBAH in
isopropyl alcohol, which is widely used in the titration of acids,
was used as titrant. The mV values that were obtained in pH-
meter were recorded. Finally, the half-neutralization potential
(HNP) values were determined by drawing the mL (TBAH)-
mV graphic.
3. Results and discussion
In this study the 3-alkyl(aryl)-4-[3,4-di-(4-nitrobenzoxy)-ben-
zylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-ones 4a–g werent activities and acidic properties of some novel 4-[3,4-di-(4-nitrobenz-
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Some properties of 4,5-dihydro-1H-1,2,4-triazol-5-one Derivatives 5prepared. The starting compounds 2a–g were prepared as de-
scribed in the literature (Ikizler and Un, 1979; Ikizler and Yuk-
sek, 1993). Compounds 4 were obtained from the reactions of
compounds 2 with 3,4-di-(4-nitrobenzoxy)-benzaldehyde 3
which were synthesized by the reactions of 3,4-dihydroxybenz-
aldehyde with 4-nitrobenzoyl chloride by using triethylamine.
Then the reactions of compounds 4a–e and 4g with acetic
anhydride were investigated, and compounds 5a–e and 5g were
prepared (Scheme 1).
The structures of seven new 3-alkyl(aryl)-4-[3,4-di-(4-nitro-
benzoxy)-benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-
ones 4a–g and six new 1-acetyl-3-alkyl(aryl)-4-[3,4-di-(4-nitro-
benzoxy)-benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-
ones 5a–e and 5g were characterized by using elemental anal-
yses and IR, 1H NMR, 13C NMR, UV and mass spectral data.
3.1. Antioxidant activity
The antioxidant activities of 13 new compounds 4a–g, 5a–e
and 5g were determined. Several methods have been used to
determine antioxidant activities and the methods used in the
study are given below:
3.1.1. Total reductive capability using the potassium ferricyanide
reduction method
The reductive capabilities of compounds were assessed by the
extent of conversion of the Fe3+/ferricyanide complex to the
Fe2+/ferrous form. The reducing powers of the compounds
were observed at different concentrations, and results were
compared with BHA, BHT and a-tocopherol. It has been ob-
served that the reducing capacity of a compound may serve as
a signiﬁcant indicator of its potential antioxidant activity
(Meir et al., 1995). The antioxidant activity of putativeNHN
N OR
N CH
3NNHCO2C2H5C
OC2H5
R
1
NHN
N
NH2
OR
2
+ NOClOCHOC
OH
OH
iii
ii
2
Scheme 1 Synthesis route of compounds 2–5: (i) Et3N, AcOEt, 0–5
reﬂux, 1 h; (a) R = CH3, (b) R = CH2CH3, (c) R = CH2C6H5
R = CH2C6H4ÆCl (m-) and (g) R = C6H5.
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which are prevention chain initiation, binding of transition me-
tal ion catalyst, decomposition of peroxides, prevention of
continued hydrogen abstraction, reductive capacity and radi-
cal scavenging (Yildirim et al., 2001).
In this study, all the amounts of the compounds showed
lower absorbance than standard antioxidants. Hence, no activ-
ities were observed to reduce metal ion complexes to their low-
er oxidation state or to take part in any electron transfer
reaction. In other words, synthesized compounds did not show
the reductive activities, but compounds 4c and 4g showed
higher activities than blank and their reductive ability was con-
centration-dependent as seen in Fig. 1. Reducing power of the
compounds and the standards were found as the following or-
der: BHA> BHT> a-tocopherol > 4c> 4g.
3.1.2. DPPH radical scavenging activity
The model of scavenging the stable DPPH radical model is a
widely used method to evaluate antioxidant activities in a rel-
atively short time compared with other methods. The effect of
antioxidants on DPPH radical scavenging was thought to be
due to their hydrogen donating ability (Baumann et al.,
1979). DPPH is a stable free radical and accepts an electron
or hydrogen radical to become a stable diamagnetic molecule
(Soares et al., 1997). The reduction capability of DPPH radi-
cals was determined by a decrease in their absorbance at
517 nm induced by antioxidants. The absorption maximum
of a stable DPPH radical in ethanol was at 517 nm. The de-
crease in absorbance of DPPH radical was caused by antioxi-
dants because of the reaction between antioxidant molecules
and radical, progresses, which resulted in the scavenging of
the radical by hydrogen donation. It is visually noticeable as
a discolouration from purple to yellow. Hence, DPPH isOC
OC
O
O
NO2
NO2
OHC
OC
OC
O
O
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C; (ii) N2H4, H2O, reﬂux, 6 h; (iii) AcOH, reﬂux, 1 h; (iv) Ac2O,
, (d) R = CH2C6H4ÆCH3 (p-), (e) R = CH2C6H4ÆCl (p-), (f)
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Figure 1 Total reductive potential of different concentrations of
compounds 4c, 4g, BHT, BHA and a-tocopherol.
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Figure 3 Scavenging effect of compounds 5a–e, 5g, BHT, BHA
and a-tocopherol at different concentrations (12.5–25–37.5 lg/
mL).
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antioxidants (Duh et al., 1999). In the study, antiradical activ-
ities of compounds and standard antioxidants such as BHA,
BHT and a-tocopherol were determined by using the DPPH
method. Scavenging effect values of compounds 4a–g, BHA
and a-tocopherol at different concentrations are given in
Figs. 2 and 3. The newly synthesized compounds except 4d
and 5d showed good activity as a radical scavenger. The radi-
cal scavenging effect of the compounds and the standards were
found as the following order: a-tocopherol > BHA> com-
pound 4c> 4g> 4f> 4b> 4e> 5g> 4a> BHT> 5e>
5a> 5b> 5c.
3.1.3. Ferrous ion chelating activity
The chelating effect towards ferrous ions by the compounds
and standards was determined. Ferrozine can quantitatively
form complexes with Fe2+. In the presence of chelating agents,
the complex formation is disrupted with the result that the red
colour of the complex is decreased. Measurement of colour
reduction therefore allows estimation of the chelating activity
of the coexisting chelator (Yamaguchi et al., 2000). Transition
metals have a pivotal role in the generation of oxygen free rad-
icals in living organism. The ferric iron (Fe3+) is the relatively
biologically inactive form of iron. However, it can be reduced
to the active Fe2+, depending on condition, particularly pH
(Strlic et al., 2002) and oxidized back through Fenton type
reactions with the production of hydroxyl radical or0
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Figure 2 Scavenging effect of compounds 4a–g, BHT, BHA and
a-tocopherol at different concentrations (12.5–25–37.5 lg/mL).
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tion of these radicals may lead to lipid peroxidation, protein
modiﬁcation and DNA damage. Chelating agents may not
activate metal ions and potentially inhibit the metal-dependent
processes (Finefrock et al., 2003). Also, the production of
highly active ROS such as O2 , H2O2 and OH is also catalysed
by free iron though Haber–Weiss reactions:
O2 þH2O2 ! O2 þOH þOH
Among the transition metals, iron is known as the most impor-
tant lipid oxidation pro-oxidant due to its high reactivity. The
ferrous state of iron accelerates lipid oxidation by breaking
down the hydrogen and lipid peroxides to reactive free radicals
via the Fenton reactions:
Fe2þ þH2O2 ! Fe3þ þOH þOH
Fe3+ ion also produces radicals fromperoxides, even though the
rate is tenfold less than that of Fe2+ ion, which is the most pow-
erful pro-oxidant among the various types of metal ions (Calis
et al., 1993). Ferrous ion chelating activities of the compounds
4, 5, EDTA and a-tocopherol are shown in Figs. 4 and 5,
respectively. It was reported that chelating agents that form
r-bonds with a metal are effective as secondary antioxidants0
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Figure 4 Metal chelating effect of different amounts of the
compounds 4a–g, EDTA and a-tocopherol on ferrous ions.
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Figure 6 Potentiometric titration curves of 0.001 M solutions of
compound 4a titrated with 0.05 M TBAH in DMF, acetone, tert-
butyl alcohol and isopropyl alcohol at 25 C.
Some properties of 4,5-dihydro-1H-1,2,4-triazol-5-one Derivatives 7because they reduce the redox potential thereby stabilizing the
oxidized form of metal ion (Gordon, 1990).
It was reported that the compounds with structures con-
taining two or more of the functional groups, such as AOH,
ASH, ACOOH, APO3H2, C‚O, ANR2, ASA, AOA in a
favourable structure–function conﬁguration should have che-
lation activity (Lindsay, 1996; Yuan et al., 2005; Gulcin,
2006). In this respect, L-carnitine may chelate the ferrous ions
with hydroxyl and carboxylate groups (Gulcin, 2006). In this
study; 4 and 5 type compounds contain C‚O groups.
Low absorbance at 562 nm indicates high metal chelating
activity. The data obtained from Figs. 4 and 5 reveal that
the metal chelating effects of the compounds 4b, 4g, 5c and
5e were concentration-dependent, the other compounds were
not. Thus, the compounds 4b, 4g, 5c and 5e demonstrate a
marked capacity for iron binding, suggesting that their action
as peroxidation protectors may be related to their iron binding
capacity. The metal chelating effect of the compounds and
standards decreased in the order of EDTA> 5e> 5c> a-
tocopherol > 4g> 4b. On the other hand, free iron is known
to have low solubility and a chelated iron complex has greater
solubility in solution, which can be contributed solely by the
ligand. Furthermore, the compound–iron complex may also
be active, since it can participate in iron-catalysed reactions.
3.2. Potentiometric titrations
In order to determine the pKa values of the compounds 4a–g,
they were titrated potentiometrically with TBAH in fourTable 1 The HNP and the corresponding pKa values of compounds
Compd. Isopropyl alcohol tert-Butyl alcohol
HNP (mV) pKa HNP (mV) pK
4a – – – –
4b – – 525 15.9
4c – – 428 11.8
4d 339 13.03 – –
4e 191 10.56 382 14.0
4f – – 591 13.8
4g – – 380 13.6
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acetone and DMF. The mV values read in each titration were
plotted against 0.05 M TBAH volumes (mL) added, and
potentiometric titration curves were obtained for all the cases.
From the titration curves, the HNP values were measured, and
the corresponding pKa values were calculated. The data ob-
tained from the potentiometric titrations were interpreted,
and the effect of the C-3 substituent in the 4,5-dihydro-1H-
1,2,4-triazol-5-one ring as well as solvent effects was studied.
As an example for the potentiometric titration curves for
0.001 M solutions of compounds 4a titrated with 0.05 M
TBAH in isopropyl alcohol, tert-butyl alcohol, DMF and ace-
tone are shown in Fig. 6.
When the dielectric permittivity of solvents is taken into
consideration, the acidity order can be given as follows:
DMF (e= 36.7) > acetone (e= 36) > isopropyl alcohol
(e= 19.4) > tert-butyl alcohol (e= 12). As seen in Table 1,
the acidity order for compound 4a is: DMF> acetone, for
compound 4b it is: DMF> acetone > tert-butyl alcohol, for4a–g in DMF, acetone, tert-butyl alcohol and isopropyl alcohol.
DMF Acetone
a HNP (mV) pKa HNP (mV) pKa
335 13.37 483 16.30
1 397 14.61 427 14.94
1 350 13.73 495 16.15
333 13.36 478 16.01
2 453 15.56 566 17.53
0 416 14.92 576 17.79
0 330 13.34 577 17.96
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tone, for compound 4d it is: isopropyl alcohol > DMF> ace-
tone, for compound 4e it is: isopropyl alcohol > tert-butyl
alcohol > DMF> acetone, while the order for compound
4g is: DMF> tert-butyl alcohol > acetone. Moreover, as
seen in Table 1, for compounds 4a in isopropyl alcohol and
tert-butyl alcohol, for compounds 4b, 4c, 4f and 4g in isopro-
pyl alcohol and for compounds 4d in tert-butyl alcohol the
HNP values and the corresponding pKa values were not
obtained.
As it is well known, the acidity of a compound depends on
some factors. The two most important factors are the solvent
effect and molecular structure (Arslantas et al., 2012; Gur-
soy-Kol et al., 2012). Table 1 and Fig. 6 show that the HNP
values and corresponding pKa values obtained from the poten-
tiometric titrations depend on the non-aqueous solvents used
and the substituents at C-3, in the 4,5-dihydro-1H-1,2,4-tria-
zol-5-one ring.
4. Conclusion
The synthesis and in vitro antioxidant evaluation of new 4,5-
dihydro-1H-1,2,4-triazol-5-one derivatives are described.
Compound 4g demonstrates a marked capacity for antioxidant
activity. The data reported with regard to the observed radical
scavenging and metal chelating activities of the studied com-
pounds could prevent redox cycling. Design and synthesis of
novel small molecules can play speciﬁcally a protective role
in biological systems and in modern medicinal chemistry.
These results may also provide some guidance for the develop-
ment of novel triazole-based therapeutic target.Acknowledgements
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